AstraZeneca PLC 6-K Filing: Major Shareholder Update & Voting Rights Insights

Here are the key insights extracted from the provided financial report (Form 6-K) for AstraZeneca PLC:

1. Filing Information:

• Type of Filing: 6-K
• Commission File Number: 001-11960
• Date of Filing: February 18, 2025

2. Issuer Details:

• Company Name: AstraZeneca PLC
• ISIN: GB0009895292
• Location: Cambridge Biomedical Campus, Cambridge, United Kingdom

3. Notification of Major Holdings:

• Reason for Notification: Acquisition or disposal of voting rights.
• Threshold Date: Voting rights threshold was crossed on January 29, 2025.
• Date Issuer Notified: January 30, 2025.

4. Shareholder Information:

• Name of Person Subject to Notification: The Capital Group Companies, Inc.
• City of Registered Office: Los Angeles, USA.

5. Voting Rights:

• Total Voting Rights Held: 77,477,644 shares.
• Percentage of Voting Rights Held: 4.996796%.
• Direct Voting Rights: 61,524,566 shares (3.967928%).
• Indirect Voting Rights: 15,953,078 shares (1.028868%).

6. Financial Instruments:

• Voting Rights from Financial Instruments: No voting rights through financial instruments reported.

7. Chain of Control:

• Ultimate Controlling Entity: The Capital Group Companies, Inc. oversees multiple affiliated investment management companies that manage assets for institutional and individual clients.

8. Additional Information:

• The shares reported are not owned by The Capital Group Companies, Inc. itself but are under the discretionary investment management of its subsidiaries.

This summary highlights important aspects of ownership changes in AstraZeneca PLC, particularly focusing on significant shareholders, voting rights, and the overall ownership structure as reported in the filing.